Arrowhead Pharmaceuticals (ARWR) Q4 2020 Earnings

23NovConfirmed
Q1 2020
Q2 2020
Q3 2020
Q4 2020
-0.48
-0.17
0.14
0.45

Details

Expected EPS
0.45
Actual EPS
-0.48
Surprise EPS
-0.93
Surprise Percent
+206.67%

Description

Arrowhead Pharmaceuticals (ARWR) has reported earnings of -0.48 per share for Q4 2020.

0 Comments

Share your thoughts